Christiane Querfeld MD, PhD, Hanjun Qin PhD, Ching-Yu Su, Zhen Han PhD, Jasmine Zain MD, Steven T. Rosen MD, Xiwei Wu PhD
{"title":"CTCL中肿瘤微环境反应的单细胞解剖:与单药Durvalumab相比,Durvalumab联合来那度胺驱动更好的免疫调节","authors":"Christiane Querfeld MD, PhD, Hanjun Qin PhD, Ching-Yu Su, Zhen Han PhD, Jasmine Zain MD, Steven T. Rosen MD, Xiwei Wu PhD","doi":"10.1016/j.ejca.2025.115813","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"229 ","pages":""},"PeriodicalIF":7.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Single-cell dissection of tumor microenvironmental response in CTCL: Durvalumab combined with lenalidomide drives superior immunomodulation compared to single-agent durvalumab\",\"authors\":\"Christiane Querfeld MD, PhD, Hanjun Qin PhD, Ching-Yu Su, Zhen Han PhD, Jasmine Zain MD, Steven T. Rosen MD, Xiwei Wu PhD\",\"doi\":\"10.1016/j.ejca.2025.115813\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11980,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":\"229 \",\"pages\":\"\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0959804925006422\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0959804925006422","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Single-cell dissection of tumor microenvironmental response in CTCL: Durvalumab combined with lenalidomide drives superior immunomodulation compared to single-agent durvalumab
期刊介绍:
The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.